Clinical Trial Update: Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of adding Sofosbuvir and Ribavirin to Grazoprevir/Elbasvir in patients with hepatitis C genotype 1 or 4 who fai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Grazoprevir/Elbasvir
• Ribavirin (ribavirin)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED